About Paxillin
Paxillin (PXN) is a protein
from Homo sapiens identified by UniProt accession
P49023, 591 residues long.
MolForge cross-references it against 0 known binders and
219 disease associations.
Target properties
| Protein name | Paxillin |
| UniProt accession | P49023 |
| Gene | PXN |
| Organism | Homo sapiens |
| Length | 591 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (219)
Diseases linked to this target (Open Targets).
- glioblastoma multiforme · score 0.28
- platelet count · score 0.25
- endometrial cancer · score 0.25
- mean corpuscular volume · score 0.25
- lung adenocarcinoma · score 0.23
- ovarian cancer · score 0.18
- head and neck squamous cell carcinoma · score 0.16
- cutaneous melanoma · score 0.12
- gastric adenocarcinoma · score 0.12
- serum gamma-glutamyl transferase measurement · score 0.12
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P49023-F1 | alphafold | PREDICTED | 65.01 | — |
Amino-acid sequence (591 residues)
MDDLDALLAD LESTTSHISK RPVFLSEETP YSYPTGNHTY QEIAVPPPVP PPPSSEALNG TILDPLDQWQ PSSSRFIHQQ PQSSSPVYGS SAKTSSVSNP QDSVGSPCSR VGEEEHVYSF PNKQKSAEPS PTVMSTSLGS NLSELDRLLL ELNAVQHNPP GFPADEANSS PPLPGALSPL YGVPETNSPL GGKAGPLTKE KPKRNGGRGL EDVRPSVESL LDELESSVPS PVPAITVNQG EMSSPQRVTS TQQQTRISAS SATRELDELM ASLSDFKIQG LEQRADGERC WAAGWPRDGG RSSPGGQDEG GFMAQGKTGS SSPPGGPPKP GSQLDSMLGS LQSDLNKLGV ATVAKGVCGA CKKPIAGQVV TAMGKTWHPE HFVCTHCQEE IGSRNFFERD GQPYCEKDYH NLFSPRCYYC NGPILDKVVT ALDRTWHPEH FFCAQCGAFF GPEGFHEKDG KAYCRKDYFD MFAPKCGGCA RAILENYISA LNTLWHPECF VCRECFTPFV NGSFFEHDGQ PYCEVHYHER RGSLCSGCQK PITGRCITAM AKKFHPEHFV CAFCLKQLNK GTFKEQNDKP YCQNCFLKLF C
Explore Paxillin with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets